Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Avience Biomedicals Limited, is a listed public company incorporated on 23 December, 2019. It is classified as a public limited company and is located in New Delhi, Delhi. It's authorized share capital is INR 7.00 cr and the total paid-up capital is INR 5.49 cr.
Avience Biomedicals Limited's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2024. It's EBITDA has increased by 126.27% over the previous year. At the same time, it's book networth has increased by 49.2%.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Janardan Pal
Shareholder
|
08647037 | 7 years |
| Director | Ram Nagina Choudhary
Shareholder
|
02804667 | 7 years |
| Managing Director | Dharam Deo Choudhary
Shareholder
|
02804625 | 7 years |
| Director | Pankaj Sharma | 07077130 | 2 years |
| Director | Deepa Choudhary | 09267149 | 2 years |
| Director | Om Prakash Pal | 10841456 | 2 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2025 available in Tofler Pro
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| AVIENCE BIOMEDICALS PRIVATE LIMITED |
Active
|
4.0 Cr | 3 | Delhi |
| AVIENCE BIOMEDICALS LIMITED |
Active
|
4.0 Cr | 6 | Delhi |
| DR MEDITECH SURGICAL AND DIAGNOSTICS (INDIA) PRIVATE LIMITED |
Active
|
33.5 L | 3 | Delhi |
| TEKNOW TRAIN AND RESEARCH INDIA PRIVATE LIMITED |
Strike Off
|
14.2 L | 1 | Haryana |
| C2C TECHNOSOFT PRIVATE LIMITED |
Active
|
1.0 L | 1 | Haryana |
| IMPERATIVE HEALTHCARE PRIVATE LIMITED |
Active
|
50,000.0 | 1 | Delhi |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| DR MEDITECH SURGICAL AND DIAGNOSTICS (INDIA) PRIVATE LIMITED | Delhi | 2010 | ₹ 33.5 L |
Read more
The incorporation date of AVIENCE BIOMEDICALS LIMITED is 23 December, 2019
The authorized share capital of AVIENCE BIOMEDICALS LIMITED is INR ₹ 7.0 Cr.
The paid-up capital of AVIENCE BIOMEDICALS LIMITED is INR ₹ 5.5 Cr.
The registered address of AVIENCE BIOMEDICALS LIMITED is C-11 BLOCK-C, COMMUNITY CENTRE New Delhi Delhi - 110058
The CIN number of AVIENCE BIOMEDICALS LIMITED is L74999DL2019PLC359158.